Two HCV viremic blood donors with unusual seroconversion HCV immunoreactivity

被引：0
|
作者：
Andrews, WW
Yan, P
Lee, W
Phelps, BH
Bzowej, N
Caglioti, S
Tobler, L
Busch, MP
机构：
[1] Chiron Blood Testing, Emeryville, CA USA
[2] Univ Calif San Francisco, Dept Med, San Francisco, CA USA
[3] Univ Calif San Francisco, Vet Affairs Med Ctr, San Francisco, CA USA
[4] Blood Syst Labs, Tempe, AZ USA
[5] Irwin Mem Blood Ctr, Blood Ctr Pacific, San Francisco, CA USA
来源：
TRANSFUSION | 2000年 / 40卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：91S / 91S
页数：1
相关论文
共 50 条
  • [21] Cost-effectiveness of Using Kidneys From HCV-Viremic Donors for Transplantation Into HCV-Uninfected Recipients
    Eckman, Mark H.
    Woodle, E. Steve
    Thakar, Charuhas, V
    Alloway, Rita R.
    Sherman, Kenneth E.
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2020, 75 (06) : 857 - 867
  • [22] HCV surrogates among blood donors implicated in HCV transmission.
    Mosley, JW
    Nowicki, MJ
    Operskalski, EA
    TRANSFUSION, 1998, 38 (10) : 72S - 72S
  • [23] Misclassification of HCV viremic blood donors as indeterminate by RIBA 3.0 due to human superoxide dismutase (hSOD)reactivity
    Tobler, LH
    Stramer, SL
    Kleinman, SH
    Brodsky, J
    Todd, D
    Wu, Y
    TRANSFUSION, 2000, 40 (10) : 78S - 78S
  • [24] Misclassification of HCV-viremic blood donors as indeterminate by RIBA 3.0 because of human superoxide dismutase reactivity
    Tobler, LH
    Stramer, SL
    Kleinman, SH
    Brodsky, JP
    Todd, DS
    Busch, MP
    TRANSFUSION, 2001, 41 (12) : 1625 - 1626
  • [25] Transplantation of HCV Viremic Livers into HCV Viremic Recipients Followed by Direct-acting Antiviral Therapy
    Kapila, Nikhil
    Al Khalloufi, Kawtar
    Flocco, Gianina
    Menon, K. V. Narayanan
    Lindenmeyer, Christina
    Reino, Diego
    Vanatta, Jason M.
    Ebaid, Samer
    Tzakis, Andreas
    Zervos, Xaralambos Bobby
    JOURNAL OF CLINICAL AND TRANSLATIONAL HEPATOLOGY, 2019, 7 (02) : 122 - 126
  • [26] DETECTION OF HCV RNA AMONG IRANIAN HCV-SEROPOSITIVE BLOOD DONORS
    Kafi-Abad, Amini S. A.
    Abdollahi, M.
    Moghtadaei, M.
    Samie, Sh
    Kermani, Ranjbar F.
    Ferdowsian, F.
    Ataie, Z.
    Tootian, S.
    Kavari, M.
    VOX SANGUINIS, 2009, 97 : 113 - 114
  • [27] ANTI-HCV ANTIBODIES AND HCV RNA IN LIBYAN BLOOD-DONORS
    ELZOUKI, ANY
    BEECHING, NJ
    MUTTON, KJ
    GARSON, JA
    VOX SANGUINIS, 1995, 68 (01) : 65 - 65
  • [28] Comprehensive Utilization of HCV Viremic and Non-Viremic Donor Livers and Kidneys into HCV-negative Patients
    de Vera, M. E.
    Woloszyn, J.
    Sterris, J.
    Robinson, M.
    Evans, R.
    Blais, S.
    Elhazin, B.
    Amador, C.
    Berk, C.
    Volk, M.
    Villicana, R.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2021, 21 : 443 - 443
  • [29] Regional Differences and Temporal Changes in the Utilization of HCV-Viremic Donors in Kidney Transplantation
    Leeaphorn, Napat
    Attieh, Rose Mary
    Wadei, Hani M.
    Mao, Shennen A.
    Mao, Michael A.
    Pungpapong, Surakit
    Taner, Burcin
    Cheungpasitporn, Wisit
    Jarmi, Tambi
    TRANSPLANTATION PROCEEDINGS, 2024, 56 (06) : 1513 - 1521
  • [30] Look back studies of anti-HCV negative/HCV RNA positive blood donors identified low viremic donation not detected by mini-pool NAT
    不详
    VOX SANGUINIS, 2005, 89 : 130 - 130
12345